Literature DB >> 6111747

Melatonin enhances guanylate cyclase activity in a variety of tissues.

D L Vesely.   

Abstract

The objective of the present investigation was to determine if melatonin at physiological concentrations might have part of its mechanism of action through enhancement of guanylate cyclase (E.C.4.6.1.2) activity. Melatonin enhanced guanylate cyclase activity two-three fold in rat anterior pituitary, thyroid, testis, ovary, liver and small intestine at the 1 nanomolar concentration. Some stimulation of hepatic guanylate cyclase activity by melatonin was seen at concentrations as low as 1 picomolar. There was no stimulation of guanylate cyclase activity at concentrations below 1 picomolar. Maximal enhancement of guanylate cyclase activity was seen at the 1 nanomolar concentration of melatonin with no further enhancement being observed with increasing the concentration to the micromolar range. Thus, the data in the present investigation indicates that at concentrations at which melatonin is known to cause physiological effects, melatonin does cause an enhancement of the activity of the guanylate cyclase-cyclic GMP system.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6111747     DOI: 10.1007/bf02358188

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  22 in total

1.  Direct action of melatonin on testosterone and cyclic GMP production using rat testis tissue in vitro.

Authors:  T Kano; Y Miyachi
Journal:  Biochem Biophys Res Commun       Date:  1976-10-04       Impact factor: 3.575

2.  Evidence for a cytoplasmic melatonin receptor.

Authors:  M Cohen; D Roselle; B Chabner; T J Schmidt; M Lippman
Journal:  Nature       Date:  1978-08-31       Impact factor: 49.962

3.  Effect of luteinizing hormone releasing hormone on accumulation of pituitary cyclic AMP and GMP in vitro.

Authors:  G L Rigler; G T Peake; A Ratner
Journal:  J Endocrinol       Date:  1978-02       Impact factor: 4.286

4.  Evidence for the involvement of guanosine 3',5'-cyclic monophosphate in the regulation of gonadotropin release.

Authors:  H Nakano; C P Fawcett; F Kimura; S M McCann
Journal:  Endocrinology       Date:  1978-11       Impact factor: 4.736

5.  Comparative physiological disposition of melatonin and its benzo(b)thiophene analog in the rat.

Authors:  R P Maickel; T R Bosin; S D Harrison; M A Riddle
Journal:  Life Sci       Date:  1974-05-01       Impact factor: 5.037

6.  Evidence of stimulation of glucagon secretion by alanine in the human fetus at term.

Authors:  J K Wise; S S Lyall; R Hendler; P Felig
Journal:  J Clin Endocrinol Metab       Date:  1973-08       Impact factor: 5.958

7.  The pineal as a neuroendocrine transducer.

Authors:  R J Wurtman
Journal:  Hosp Pract       Date:  1980-01

8.  In vitro effects of melatonin on HCG stimulation of steroid accumulation by rabbit ovarian follicles.

Authors:  E V YoungLai
Journal:  J Steroid Biochem       Date:  1979-06       Impact factor: 4.292

9.  Effect of melatonin on thyroid hormone secretion rate and feed consumption of female rats.

Authors:  G D Narang; D V Singh; C W Turner
Journal:  Proc Soc Exp Biol Med       Date:  1967-05

10.  Testosterone and its precursors and metabolites enhance guanylate cyclase activity.

Authors:  D L Vesely
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

View more
  1 in total

1.  Rapid changes in specific estrogen binding elicited by cGMP or cAMP in cytosol from human endometrial cells.

Authors:  H Fleming; R Blumenthal; E Gurpide
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.